"Deferiprona, tamb\u00E9m conhecido pelo nome comercial Ferriprox, \u00E9 um f\u00E1rmaco usado como agente quelante do ferro. \u00C9 usado no tratamento de talassemia. A deferiprona \u00E9 um tratamento alternativo para a sobrecarga de ferro em pacientes com talassemia major incapazes de receber a desferroxamina."@pt . "30652-11-0" . . "D"@en . "70927"^^ . . . . "Deferypron (\u0142ac. Deferipronum) \u2013 zwi\u0105zek chelatuj\u0105cy \u017Celazo, stosowany w leczeniu talasemii."@pl . "Il deferiprone \u00E8 un principio attivo che agisce come ferrochelante; esso \u00E8 indicato secondo l'RCP nel trattamento dell'accumulo di ferro (emosiderosi) nei pazienti affetti da talassemia maggiore, quando la terapia con deferoxamina \u00E8 controindicata o non adeguata. Il farmaco \u00E8 stato studiato dalla ApoPharma. In Italia \u00E8 commercializzato dalla Chiesi Farmaceutici dal 1999, con il nome: Ferriprox."@it . "D"@en . . . . . "2BTY8KH53L" . . "10209"^^ . . "10800.0"^^ . "Il deferiprone \u00E8 un principio attivo che agisce come ferrochelante; esso \u00E8 indicato secondo l'RCP nel trattamento dell'accumulo di ferro (emosiderosi) nei pazienti affetti da talassemia maggiore, quando la terapia con deferoxamina \u00E8 controindicata o non adeguata. Il farmaco \u00E8 stato studiato dalla ApoPharma. In Italia \u00E8 commercializzato dalla Chiesi Farmaceutici dal 1999, con il nome: Ferriprox."@it . "Deferiprone"@en . . "yes"@en . "POM"@en . "1"^^ . . "\u062F\u064A\u0641\u064A\u0631\u064A\u0628\u0631\u0648\u0646 \u0647\u0648 \u062F\u0648\u0627\u0621 \u064A\u062A\u0645\u062E\u0644\u0628 \u0628\u0627\u0644\u062D\u062F\u064A\u062F \u0648\u064A\u0633\u062A\u0639\u0645\u0644 \u0641\u064A \u0639\u0644\u0627\u062C \u0627\u0644\u062A\u062D\u0645\u064A\u0644 \u0627\u0644\u0645\u0641\u0631\u0637 \u0644\u0644\u062D\u062F\u064A\u062F \u0641\u064A \u0627\u0644\u062B\u0644\u0627\u0633\u064A\u0645\u064A\u0629 \u0627\u0644\u0643\u0628\u0631\u0649. \u0631\u062E\u0635 \u0627\u0633\u062A\u0639\u0645\u0627\u0644\u0647 \u0623\u0648\u0644 \u0645\u0631\u0629 \u0641\u064A \u0639\u0644\u0627\u062C \u0627\u0644\u062B\u0644\u0627\u0633\u064A\u0645\u064A\u0629 \u0627\u0644\u0643\u0628\u0631\u0649 \u0641\u064A \u0639\u0627\u0645 1994 \u0648\u0642\u062F \u062D\u0635\u0644 \u0639\u0644\u0649 \u0627\u0644\u062A\u0631\u062E\u064A\u0635 \u0623\u0648\u0644\u0627 \u0641\u064A \u0623\u0648\u0631\u0648\u0628\u0627 \u0648\u0622\u0633\u064A\u0627 \u0644\u0643\u0646\u0647 \u0627\u0646\u062A\u0638\u0631 \u0633\u0646\u0648\u0627\u062A \u0639\u062F\u064A\u062F\u0629 \u0642\u0628\u0644 \u062A\u0631\u062E\u064A\u0635\u0647 \u0641\u064A \u0643\u0646\u062F\u0627 \u0648\u0627\u0644\u0648\u0644\u0627\u064A\u0627\u062A \u0627\u0644\u0645\u062A\u062D\u062F\u0629. \u0641\u0641\u064A 14 \u0623\u0643\u062A\u0648\u0628\u0631 2011, \u062D\u0635\u0644 \u0639\u0644\u0649 \u0645\u0648\u0627\u0641\u0642\u0629 \u0641\u064A \u0627\u0644\u0648\u0644\u0627\u064A\u0627\u062A \u0627\u0644\u0645\u062A\u062D\u062F\u0629 \u062A\u062D\u062A \u0644\u0625\u062F\u0627\u0631\u0629 \u0627\u0644\u063A\u0630\u0627\u0621 \u0648\u0627\u0644\u062F\u0648\u0627\u0621."@ar . "TZXKOCQBRNJULO-UHFFFAOYSA-N"@en . . "DB08826" . . "Deferiprone"@en . . "Rx-only"@en . . "30652"^^ . "70927" . "9"^^ . "Deferiprona"@pt . "S4"@en . . . "Rx-only"@en . . "Deferiprona, tamb\u00E9m conhecido pelo nome comercial Ferriprox, \u00E9 um f\u00E1rmaco usado como agente quelante do ferro. \u00C9 usado no tratamento de talassemia. A deferiprona \u00E9 um tratamento alternativo para a sobrecarga de ferro em pacientes com talassemia major incapazes de receber a desferroxamina."@pt . . "D\u00E9f\u00E9riprone"@fr . "V03"@en . "Deferypron (\u0142ac. Deferipronum) \u2013 zwi\u0105zek chelatuj\u0105cy \u017Celazo, stosowany w leczeniu talasemii."@pl . "\u062F\u064A\u0641\u064A\u0631\u064A\u0628\u0631\u0648\u0646"@ar . "Le d\u00E9f\u00E9riprone est une mol\u00E9cule ch\u00E9latrice du fer, utilis\u00E9 comme m\u00E9dicament dans les surcharges en fer."@fr . "Deferiprone, sold under the brand name Ferriprox among others, is a medication that chelates iron and is used to treat iron overload in thalassaemia major. It was first approved and indicated for use in treating thalassaemia major in 1994 and had been licensed for use in the European Union for many years while awaiting approval in Canada and in the United States. On October 14, 2011, it was approved for use in the US under the FDA's accelerated approval program. The most common side effects include red-brown urine (showing that iron is being removed through the urine), nausea (feeling sick), abdominal pain (stomach ache) and vomiting. Less common but more serious side effects are agranulocytosis (very low levels of granulocytes, a type of white blood cell) and neutropenia (low levels of neutrophils, a type of white blood cell that fights infections)."@en . "9494348"^^ . "D07416"@en . . "/ P"@en . . "3"^^ . . . . . "2"^^ . "a612016"@en . . . . . . . . . . . . "Ferriprox"@en . . "DB08826"@en . . "Le d\u00E9f\u00E9riprone est une mol\u00E9cule ch\u00E9latrice du fer, utilis\u00E9 comme m\u00E9dicament dans les surcharges en fer."@fr . "1105534631"^^ . "7"^^ . . "Rx-only"@en . . "O=C\\1C=CC"@en . . "68554"^^ . "\u062F\u064A\u0641\u064A\u0631\u064A\u0628\u0631\u0648\u0646 \u0647\u0648 \u062F\u0648\u0627\u0621 \u064A\u062A\u0645\u062E\u0644\u0628 \u0628\u0627\u0644\u062D\u062F\u064A\u062F \u0648\u064A\u0633\u062A\u0639\u0645\u0644 \u0641\u064A \u0639\u0644\u0627\u062C \u0627\u0644\u062A\u062D\u0645\u064A\u0644 \u0627\u0644\u0645\u0641\u0631\u0637 \u0644\u0644\u062D\u062F\u064A\u062F \u0641\u064A \u0627\u0644\u062B\u0644\u0627\u0633\u064A\u0645\u064A\u0629 \u0627\u0644\u0643\u0628\u0631\u0649. \u0631\u062E\u0635 \u0627\u0633\u062A\u0639\u0645\u0627\u0644\u0647 \u0623\u0648\u0644 \u0645\u0631\u0629 \u0641\u064A \u0639\u0644\u0627\u062C \u0627\u0644\u062B\u0644\u0627\u0633\u064A\u0645\u064A\u0629 \u0627\u0644\u0643\u0628\u0631\u0649 \u0641\u064A \u0639\u0627\u0645 1994 \u0648\u0642\u062F \u062D\u0635\u0644 \u0639\u0644\u0649 \u0627\u0644\u062A\u0631\u062E\u064A\u0635 \u0623\u0648\u0644\u0627 \u0641\u064A \u0623\u0648\u0631\u0648\u0628\u0627 \u0648\u0622\u0633\u064A\u0627 \u0644\u0643\u0646\u0647 \u0627\u0646\u062A\u0638\u0631 \u0633\u0646\u0648\u0627\u062A \u0639\u062F\u064A\u062F\u0629 \u0642\u0628\u0644 \u062A\u0631\u062E\u064A\u0635\u0647 \u0641\u064A \u0643\u0646\u062F\u0627 \u0648\u0627\u0644\u0648\u0644\u0627\u064A\u0627\u062A \u0627\u0644\u0645\u062A\u062D\u062F\u0629. \u0641\u0641\u064A 14 \u0623\u0643\u062A\u0648\u0628\u0631 2011, \u062D\u0635\u0644 \u0639\u0644\u0649 \u0645\u0648\u0627\u0641\u0642\u0629 \u0641\u064A \u0627\u0644\u0648\u0644\u0627\u064A\u0627\u062A \u0627\u0644\u0645\u062A\u062D\u062F\u0629 \u062A\u062D\u062A \u0644\u0625\u062F\u0627\u0631\u0629 \u0627\u0644\u063A\u0630\u0627\u0621 \u0648\u0627\u0644\u062F\u0648\u0627\u0621."@ar . . . . . . "2972" . . . . . . "Deferiprone, sold under the brand name Ferriprox among others, is a medication that chelates iron and is used to treat iron overload in thalassaemia major. It was first approved and indicated for use in treating thalassaemia major in 1994 and had been licensed for use in the European Union for many years while awaiting approval in Canada and in the United States. On October 14, 2011, it was approved for use in the US under the FDA's accelerated approval program."@en . . "443270530"^^ . "68554" . . . "AC02"@en . . . . . . . . . "changed"@en . . . . "Deferiprone"@en . "Deferiprone"@it . "changed"@en . "Ferriprox"@en . "a612016" . . . . "120"^^ . . "2972"^^ . . . . . . "7456"^^ . . . "Deferypron"@pl . "1"^^ . . "D07416" . . "2"^^ . . "2866"^^ . . .